We are monitoring the impact of COVID-19 on Respiratory Inhaler Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6146
Share on
Share on

Global Respiratory Inhaler Market Size, Share, Trends, Growth Analysis Report - Segmented By Product (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer (Compressed Air Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers)), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, Others Respiratory Disease) and Region - Industry Forecast | 2019 - 2024

Pulished: February, 2020
ID: 6146
Pages: 175

Global Respiratory Inhaler Market Size & Growth (2019 - 2024):

Globally, the size of the respiratory inhaler market is to grow at a CAGR of 4.4% from 2019 to 2024. Respiratory inhalers are the devices used by the people who are suffering from breathing problems like asthma, fibrosis and others.

The growing pervasiveness of asthma, COPD and other respiratory diseases are the principal growth drivers to the market.

As per the CDC, in America, in 2019, the asthma was found in 1 in every 13 people, and 25 million population had asthma. Asthma and Allergy Foundation of America has stated that 10 American were dead each day due to asthma in the year 2017. Around 3,564 asthma deaths were reported.

The Global Initiative for Chronic Obstructive Lung Disease estimates, the COPD to become the third leading cause for the deaths in the world by 2020.

Additionally, lifestyle habits like smoking are to surge up the demand. Pollution that is caused by the industries in the urban areas is the major factors that are boosting up the market. Advance technologies in developing new products for inhaling are likely to leverage the demand of the respiratory inhaler market.

Increase in ageing population, convenient inhaling devices that are readily available in the market, the emergence of e-commerce in pharmacy are the factors that are responsible for boosting up the market growth. Combination therapy is for in COPD, and this is to propel the growth rate of the respiratory inhaler market. 

Fluctuations in the availability of raw materials are inhibiting the demand of the market. Side effects and difficulties that may be caused by using some of the inhaling devices is limiting the growth rate of the respiratory inhaler market. Lack of expert pulmonologists, physicians and medical staff like a nurse and people having less or no knowledge about the inhalation devices are likely to restrain the market growth.

Recent happenings in this market

On April 09, 2020, Cipla Ltd has received the U.S. FDA acceptance for generic Albuterol Sulfate inhalation which is for the treatment of asthmatic symptoms. It will enhance the strength of the company’s position in the market and lead to launch many more inhalation products. 

On January 08, 2020, Teva Pharmaceuticals has developed the digitally integrated Inhaler that was approved by the U.S. FDA. The device includes sensors where the patient and caregivers can communicate using a mobile app. 

In September 2017, the FDA approved GSK’s Trelegy Ellipta for the people who are suffering from respiratory problems. It is beneficial for patients suffering from chronic pulmonary obstructive disease. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018-2024

Base Year

2018

Forecast Period

2019-2024

Segments Covered

By Product, Technology, Disease Indication and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the Global Respiratory Inhaler Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Respiratory Inhaler Market Analysis – By Product

  • Dry Powder Inhaler             
  • Metered Dose Inhaler       
  • Nebulizer 
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizer

Based on the product type, the metered-dose inhaler (MDI) segment to dominate the market with the highest market share followed by dry powder inhaler product segment.

Respiratory Inhaler Market Analysis – By Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • Validation Biomarkers

Based on technology, the manually operated inhaler devices segment is occupying lion share of the market, whereas, the digitally produced devices are to grow at the highest CAGR during the forecast period.

Respiratory Inhaler Market Analysis – By Disease Indication

  • Asthma     
  • COPD         
  • Pulmonary Arterial Hypertension  
  • Others Respiratory Disease

Based on disease indication, in 2019, the COPD segment was the leader in the market and to continue the same growing demand throughout the projection period.  

Regional Analysis

As of 2019, North America held a significant share of 41% in the overall respiratory inhaler devices market due to the growing number of COPD disease cases in this region. In North America, the United States and Canada markets are to grow at a healthy rate due to the growing product awareness.

Europe was at the 2nd position in leading the majority of the shares in the market. Majority of the leading manufacturers of respiratory devices present in the European countries, and this cause is providing a required boost for the market to establish in this region.

Besides, the Asia Pacific is to witness the highest growth rate in the coming years. The growing ageing population and rising healthcare spending in this region are helping the respiratory inhalers market to grow.

Regions like Latin America, the Middle East and Africa are to have decent growth rate during the forecast period.

Key market participants leading the Global Respiratory Inhaler Market profiled in this report are:

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Dry Powder Inhaler             

                                5.1.3 Metered Dose Inhaler       

                                5.1.4 Nebulizer 

                                                5.1.4.1 Compressed Air Nebulizers

                                                5.1.4.2 Ultrasonic Nebulizers

                                                5.1.4.3 Mesh Nebulizers

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Technology                 

                                5.2.1 Introduction           

                                5.2.2 Manually Operated Inhaler Devices             

                                5.2.3 Digitally Operated Inhaler Devices

                                5.2.4 Validation Biomarkers        

                                5.2.5 Y-o-Y Growth Analysis, By Technology        

                                5.2.6 Market Attractiveness Analysis, By Technology      

                                5.2.7 Market Share Analysis, By Technology        

                5.3 Disease Indication                   

                                5.3.1 Introduction           

                                5.3.2 Asthma     

                                5.3.3 COPD         

                                5.3.4 Pulmonary Arterial Hypertension  

                                5.3.5 Others Respiratory Disease             

                                5.3.6 Y-o-Y Growth Analysis, By Disease Indication           

                                5.3.7 Market Attractiveness Analysis, By Disease Indication         

                                5.3.8 Market Share Analysis, By Disease Indication          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Disease Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Disease Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Disease Indication

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 AstraZeneca                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beximco Pharmaceuticals Ltd.                            

                8.3 Boehringer Ingelheim GmbH                              

                8.4 Cipla Ltd.                      

                8.5 GlaxoSmithKline plc                

                8.6 Koninklijke Philips N.V.                          

                8.7 Merck & Co. Inc.                       

                8.8 OMRON Healthcare Europe B.V.                       

                8.9 PARI Medical Holding                             

                8.10 Teva Pharmaceutical Industries Ltd                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Technology with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Respiratory Inhaler  Market By Region, From 2019-2024 ( USD Billion )
  2. Global Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  3. Global Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  4. Global Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  5. Global Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  6. Global Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  7. Global Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  8. Global Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  9. Global Asthma Market By Region, From 2019-2024 ( USD Billion )
  10. Global COPD Market By Region, From 2019-2024 ( USD Billion )
  11. Global Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  12. Global Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  13. North America Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  14. North America Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  15. North America Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  16. North America Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  17. North America Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  18. North America Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  19. North America Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  20. North America Asthma Market By Region, From 2019-2024 ( USD Billion )
  21. North America COPD Market By Region, From 2019-2024 ( USD Billion )
  22. North America Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  23. North America Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  24. United States Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  25. United States Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  26. Canada Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  27. Canada Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  28. Europe Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  29. Europe Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  30. Europe Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  31. Europe Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  32. Europe Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  33. Europe Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  34. Europe Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  35. Europe Asthma Market By Region, From 2019-2024 ( USD Billion )
  36. Europe COPD Market By Region, From 2019-2024 ( USD Billion )
  37. Europe Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  38. Europe Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  39. U.K. Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  40. U.K. Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  41. Germany Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  42. Germany Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  43. France Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  44. France Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  45. Italy Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  46. Italy Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  47. Spain Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  48. Spain Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  49. Asia Pacific Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  50. Asia Pacific Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  51. Asia Pacific Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  52. Asia Pacific Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  53. Asia Pacific Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  54. Asia Pacific Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  55. Asia Pacific Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  56. Asia Pacific Asthma Market By Region, From 2019-2024 ( USD Billion )
  57. Asia Pacific COPD Market By Region, From 2019-2024 ( USD Billion )
  58. Asia Pacific Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  59. Asia Pacific Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  60. Japan Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  61. Japan Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  62. China Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  63. China Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  64. India Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  65. India Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  66. Australia Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  67. Australia Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  68. South Korea Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  69. South Korea Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  70. Latin America Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  71. Latin America Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  72. Latin America Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  73. Latin America Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  74. Latin America Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  75. Latin America Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  76. Latin America Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  77. Latin America Asthma Market By Region, From 2019-2024 ( USD Billion )
  78. Latin America COPD Market By Region, From 2019-2024 ( USD Billion )
  79. Latin America Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  80. Latin America Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  81. Brazil Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  82. Brazil Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  83. Argentina Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  84. Argentina Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  85. Mexico Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  86. Mexico Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  87. Rest of Latin America Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  88. Rest of Latin America Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  89. Middle East and Africa Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  90. Middle East and Africa Dry Powder Inhaler Market By Region, From 2019-2024 ( USD Billion )
  91. Middle East and Africa Metered Dose Inhaler Market By Region, From 2019-2024 ( USD Billion )
  92. Middle East and Africa Nebulizer   Market By Region, From 2019-2024 ( USD Billion )
  93. Middle East and Africa Manually Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  94. Middle East and Africa Digitally Operated Inhaler Devices Market By Region, From 2019-2024 ( USD Billion )
  95. Middle East and Africa Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  96. Middle East and Africa Asthma Market By Region, From 2019-2024 ( USD Billion )
  97. Middle East and Africa COPD Market By Region, From 2019-2024 ( USD Billion )
  98. Middle East and Africa Pulmonary Arterial Hypertension Market By Region, From 2019-2024 ( USD Billion )
  99. Middle East and Africa Others Respiratory Disease Market By Region, From 2019-2024 ( USD Billion )
  100. Middle East Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  101. Middle East Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )
  102. Africa Respiratory Inhaler  Market By Product, From 2019-2024 ( USD Billion )
  103. Africa Respiratory Inhaler  Market By Disease Indication, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample